EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Beta 2 ‐adrenergic agonist salbutamol exhibits enantioselective disposition in skeletal muscle of lean young men following oral administration

Morten Hostrup iD, Glenn A Jacobson iD, Kasper Eibye, Christian K Narkowicz, David S Nichols, Søren Jessen iD

Drug Testing and Analysis · 2025

DOI: 10.1002/dta.3787 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Morten Hostrup und 5 weiteren Autor:innen. Beteiligte Einrichtung: August Krogh Section for Human Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Albuterol, Adrenergic beta-2 Receptor Agonists, Muscle, Skeletal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Danish Ministry of Culture (Sports Science), Anti Doping Danmark, Kulturministeriet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Salbutamol is a common short‐acting beta 2 ‐adrenergic agonist used in treatment of asthma and exercise‐induced bronchoconstriction but also possesses anabolic and metabolic actions in skeletal muscle. As a chiral compound, salbutamol is a racemic 1:1 mixture of two enantiomers, (R)‐salbutamol and (S)‐salbutamol, which exhibit divergent pharmacokinetic and pharmacodynamic actions. Despite salbutamol being available for decades, information on the enantioselective disposition of salbutamol enantiomers in human skeletal muscle is absent. In this study, we determined concentrations of (R)‐salbutamol and (S)‐salbutamol by UHPLC–MS/MS in arterial plasma and vastus lateralis muscle samples from 12 lean young men 2½ and 7 h following ingestion of 24 mg oral salbutamol. Mean (range) arterial plasma concentrations were 10‐fold higher ( p < 0.001) for (S)‐salbutamol than (R)‐salbutamol, being 33(9–62) and 49(30–84) ng·mL −1 for (S)‐salbutamol and 4 (1‐6) and 4 (2‐5) ng·mL −1 for (R)‐salbutamol 2½ and 7 h following administration, respectively, reflecting faster elimination of the (R)‐enantiomer. Mean (range) muscle concentrations were higher (p < 0.001) for (S)‐salbutamol than (R)‐salbutamol 2½ h (0.17 [0.1–0.26] vs. 0.04 [0.02–0.06]) and 7 h (0.31 [0.21–0.46] vs. 0.06 [0.04–0.12] ng·mg d.w. −1 ) after administration. However, muscle:plasma partition coefficient was two‐fold higher ( p < 0.001) for (R)‐salbutamol than (S)‐salbutamol 7 h following administration. These observations demonstrate that oral salbutamol exhibits enantioselective disposition in systemic circulation and muscle favoring the (S)‐enantiomer but with higher relative partitioning of the (R)‐enantiomer in skeletal muscle. Furthermore, the concentration‐time profiles of salbutamol enantiomers are different in skeletal muscle and systemic circulation following oral ingestion. These findings have implications for the application of chiral switch (R)‐salbutamol in doping control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlbuterolAdrenergic beta-2 Receptor AgonistsMuscle, SkeletalHumansMaleStereoisomerismAdministration, OralYoung AdultTandem Mass SpectrometryAdultChromatography, High Pressure Liquid

Stichwörter der Autor:innen

SABAalbuterolbeta‐2levalbuterolpharmacokinetics

Substanzen

AlbuterolAdrenergic beta-2 Receptor Agonists

Autor:innen und Institutionen

  • August Krogh Section for Human Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.
  • School of Pharmacy and Pharmacology, College of Health and Medicine, University of Tasmania, Hobart, Australia.
  • Central Science Laboratory, University of Tasmania, Hobart, Australia.

ORCID-Profile: Morten Hostrup, Glenn A Jacobson, Søren Jessen

Förderung

  • Danish Ministry of Culture (Sports Science)
  • Anti Doping Danmark
  • Kulturministeriet

Zitieren

APA

Hostrup, M., Jacobson, G. A., Eibye, K., Narkowicz, C. K., Nichols, D. S., & Jessen, S. (2025). Beta 2 ‐adrenergic agonist salbutamol exhibits enantioselective disposition in skeletal muscle of lean young men following oral administration. Drug Testing and Analysis. https://doi.org/10.1002/dta.3787

Vancouver

Hostrup M, Jacobson GA, Eibye K, Narkowicz CK, Nichols DS, Jessen S. Beta 2 ‐adrenergic agonist salbutamol exhibits enantioselective disposition in skeletal muscle of lean young men following oral administration. Drug Testing and Analysis. 2025. doi:10.1002/dta.3787

BibTeX
@article{Hostrup2025,
  author = {Hostrup, Morten and Jacobson, Glenn A and Eibye, Kasper and Narkowicz, Christian K and Nichols, David S and Jessen, Søren},
  title = {Beta 2 ‐adrenergic agonist salbutamol exhibits enantioselective disposition in skeletal muscle of lean young men following oral administration},
  journal = {Drug Testing and Analysis},
  year = {2025},
  doi = {10.1002/dta.3787}
}
Kostenlos starten →